Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home
Share
Compartir

Funding Opportunity Announcement (FOA) PS10-10138: Expanded Human Immunodeficiency Virus (HIV) Testing for Disproportionately Affected Populations

WELCOME!

This Web site is designed to facilitate the application process for Health Departments applying for funding under Program Announcement PS10-10138.

Funding Opportunity PS10-10138

Important Notice

The due date for applications submitted under PS10-10138: Expanded Human Immunodeficiency Virus (HIV) Testing for Disproportionately Affected Populations has been extended to June 24, 2010. An amendment to the FOA was posted to Grants.gov on May 28, 2010. If you have not yet submitted your application, please download a new application package from Grants.gov as it will reflect the updated deadline date and permit your submission.

If you have already submitted your application, there is no need to resubmit. Any questions about resubmission should be directed to the CDC Procurement and Grants Office.

Telephone: 770-488-2700
Email: PGOTIM@cdc.gov 

Executive Summary

The Centers for Disease Control and Prevention announces the availability of fiscal year 2010 funds for a cooperative agreement program for health departments to increase HIV testing opportunities for populations disproportionately affected by HIV –– primarily (1) African American and Hispanic men and women, and (2) men who have sex with men (MSM) and injection drug users (IDUs), regardless of race or ethnicity –– and increase the proportion of HIV-infected persons in these populations who are aware of their infection and are linked to appropriate services. The program is also intended to identify strategies for leveraging resources to maximize the yield and sustainability of routine HIV screening programs in healthcare settings (for example, working with participating healthcare facilities to implement strategies for obtaining reimbursement for HIV screening from 3rd party payers, promoting routine HIV screening in healthcare facilities not directly involved in the program). This FOA represents an expansion of the initial 3-year Expanded HIV Testing Initiative which was funded under program announcement PS 07-768.

This FOA is limited to health departments in jurisdictions with at least 175 estimated combined AIDS diagnoses among Blacks/African Americans and Latinos in 2007. Eligible jurisdictions are as follows: Alabama, Arizona, California, Chicago, Connecticut, District of Columbia, Florida, Georgia, Houston, Illinois, Los Angeles, Louisiana, Maryland, Massachusetts, Michigan, Mississippi, Missouri, New Jersey, New York City, New York State, North Carolina, Ohio, Pennsylvania, Philadelphia, Puerto Rico, San Francisco, South Carolina, Tennessee, Texas, and Virginia. This includes five new jurisdictions that were not included in the initial program under PS 07-768: Alabama, Arizona, Illinois, Puerto Rico, and San Francisco. The jurisdictions that are eligible for this program accounted for the following percentages of AIDS diagnoses among these populations in the United States in 2007: Blacks/African Americans – 94%, Latinos – 91%, MSM – 86%, IDUs – 93%, and MSM/IDUs – 85%. Community-based organizations; for-profit entities; public non-profit, private non-profit, faith-based, and tribal organizations; and colleges and universities are not eligible to apply for funding under this FOA.

 


 

Find an HIV testing site near you.

For additional HIV services, select the "More" tab.

Search location, such as: "Atlanta, GA", or "30033".

For more information on this widget, please visit www.aids.gov

Please contact hivwebmaster@cdc.gov with any comments, suggestions, or concerns.

Services








Syndicate This Content Podcast button Tell us what you think button CDC-INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO